Methylphenidate reorganizes cortical hierarchy through dopaminergic modulation

D Dardo Tomasi (Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH) P Peter Manza (Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH) Şükrü Barış Demiral (Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH) W Weizheng Yan K Kylee B. Miller F Faith Veenker J Joshua Zhao C Christina Lildharrie (Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH) M Michele-Vera Yonga S Sarah Abey M Michaelene VanDine G Gene-Jack Wang (Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH) N Nora D. Volkow (Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH)

Abstract

Abstract Dopaminergic signaling shapes large-scale brain network architecture, constraining neural communication along a principal gradient that spans unimodal sensorimotor to transmodal association cortices. While more differentiated gradients are typically linked to enhanced cognition, it remains unclear whether dopamine-enhancing psychostimulants, such as methylphenidate (MP), amplify or compress this functional hierarchy to support attention. Across two double-blind, placebo-controlled studies in healthy adults (n = 38 and n = 20), we combined 60 mg oral MP with PET and fMRI to assess striatal dopamine function and cortical organization. MP consistently compressed the principal gradient, reducing segregation between sensory and association areas. The degree of compression predicted individual variation in striatal D1 and D2 receptor availability. MP-induced gradient compression in inferior parietal cortex tracked attention improvements. Critically, we validated key findings in a large, independent cohort from the Adolescent Brain Cognitive Development (ABCD) study (n = 4,958). These results highlight a dopamine-sensitive mechanism linking cortical functional reorganization with cognitive performance.

Article Details

Volume / Issue Vol. 17, Issue 1
Published December 13, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (13)

D

Dardo Tomasi

Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH

P

Peter Manza

Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH

Şükrü Barış Demiral

Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH

W

Weizheng Yan

K

Kylee B. Miller

F

Faith Veenker

J

Joshua Zhao

C

Christina Lildharrie

Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH

M

Michele-Vera Yonga

S

Sarah Abey

M

Michaelene VanDine

G

Gene-Jack Wang

Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH

N

Nora D. Volkow

Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, NIH